Insider Transactions in Q1 2024 at Sabra Health Care Reit, Inc. (SBRA)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Jessica Flores Executive VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,291
-3.72%
|
$29,783
$13.99 P/Share
|
|
Mar 01
2024
|
Jessica Flores Executive VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
5,976
+8.85%
|
-
|
|
Feb 29
2024
|
Richard K Matros Chair, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
14,317
+2.07%
|
-
|
|
Feb 29
2024
|
Michael Lourenco Costa Executive VP, CFO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,089
+1.23%
|
-
|
|
Feb 29
2024
|
Talya Nevo Hacohen Executive VP, CIO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
4,692
+1.65%
|
-
|
|
Feb 29
2024
|
Jessica Flores Executive VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
409
+0.73%
|
-
|
|
Feb 29
2024
|
Craig A. Barbarosh Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,040
+1.89%
|
-
|
|
Feb 29
2024
|
Catherine Cusack Director |
BUY
Grant, award, or other acquisition
|
Direct |
729
+1.82%
|
-
|
|
Feb 29
2024
|
Michael J Foster Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,040
+1.39%
|
-
|
|
Feb 29
2024
|
Lynne S Katzmann Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,108
+2.08%
|
-
|
|
Feb 29
2024
|
Ann Kono Director |
BUY
Grant, award, or other acquisition
|
Direct |
741
+2.08%
|
-
|
|
Feb 29
2024
|
Jeffrey A. Malehorn Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,040
+1.24%
|
-
|
|
Feb 29
2024
|
Clifton J Porter Ii Director |
BUY
Grant, award, or other acquisition
|
Direct |
754
+2.05%
|
-
|
|
Jan 31
2024
|
Richard K Matros Chair, CEO and President |
BUY
Grant, award, or other acquisition
|
Direct |
162,466
+19.7%
|
-
|
|
Jan 31
2024
|
Michael Lourenco Costa Executive VP, CFO & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
23,209
+8.68%
|
-
|
|
Jan 31
2024
|
Talya Nevo Hacohen Executive VP, CIO & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
51,060
+15.68%
|
-
|
|
Jan 31
2024
|
Jessica Flores Executive VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,382
-2.45%
|
$17,966
$13.34 P/Share
|
|
Jan 31
2024
|
Jessica Flores Executive VP & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
3,266
+5.46%
|
-
|
|
Jan 05
2024
|
Michael Lourenco Costa Executive VP, CFO & Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
468
-0.21%
|
$6,084
$13.64 P/Share
|
|
Jan 05
2024
|
Talya Nevo Hacohen Executive VP, CIO & Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
17,684
-7.33%
|
$229,892
$13.64 P/Share
|
|
Jan 05
2024
|
Jessica Flores Executive VP & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,359
-2.49%
|
$17,667
$13.64 P/Share
|
|
Jan 05
2024
|
Richard K Matros Chair, CEO and President |
BUY
Bona fide gift
|
Indirect |
93,042
+5.94%
|
-
|
|
Jan 05
2024
|
Richard K Matros Chair, CEO and President |
SELL
Bona fide gift
|
Direct |
93,042
-15.69%
|
-
|
|
Jan 05
2024
|
Richard K Matros Chair, CEO and President |
SELL
Payment of exercise price or tax liability
|
Direct |
66,016
-10.02%
|
$858,208
$13.64 P/Share
|